- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07287982
En undersøgelse til vurdering af sikkerhed, tolerabilitet, effekt, farmakokinetik og immunogenicitet af intravenøs administration af ARGX-119 hos børnedeltagere i alderen 5 til under 18 år med spinal muskelatrofi (Sparkle)
En fase 2-dobbeltblindet, randomiseret, placebo-kontrolleret undersøgelse for at vurdere sikkerheden, tolerabiliteten, effekten, farmakokinetikken og immunogeniciteten af intravenøs administration af ARGX-119 hos børnedeltagere i alderen 5 til under 18 år med spinal muskelatrofi
This study aims to find the correct dose of ARGX-119 for children with SMA. The study will also look at how safe the study drug is, how well it works, how it moves through the body, and how the immune system responds to it. The study consists of a double-blinded treatment period (DBTP) where participants will either receive ARGX-119 IV or placebo IV, in addition to disease-modifying therapy (DMT) for 24 weeks. Participants who complete the DBTP will enter the open-label active-treatment extension period (ATEP) during which all participants will receive ARGX-119 IV up to 100 weeks (approximately 2 years).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This phase 2 study aims to establish proof of concept with the age-appropriate dose of ARGX-119 in ambulant pediatric patients with spinal muscular atrophy (SMA). Despite available treatments, there remains an unmet medical need for patients with SMA. Neuromuscular junction (NMJ) dysfunction contributes to the pathophysiology of SMA, including muscle weakness and fatigability. Activation of muscle-specific kinase (MuSK) by ARGX-119 may stabilize and improve NMJ function in patients with SMA, reducing muscle weakness and fatigability, and improving quality of life.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
- Navn: Sabine Coppieters, MD
- Telefonnummer: 857-350-4834
- E-mail: Clinicaltrials@argenx.com
Studiesteder
-
-
New South Wales
-
Randwick, New South Wales, Australien, 2031
- Rekruttering
- Sydney Children's Hospital, Randwick
-
Ledende efterforsker:
- Michelle Farrar
-
Kontakt:
- Michelle Farrar
- Telefonnummer: 61293821549
- E-mail: michelle.farrar@health.nsw.gov.au
-
-
Victoria
-
Parkville, Victoria, Australien, 3052
- Ikke rekrutterer endnu
- Royal Children's Hospital
-
Kontakt:
- Eppie Yiu
- Telefonnummer: +61412599077
- E-mail: eppie.yiu@rch.org.au
-
Ledende efterforsker:
- Eppie Yiu
-
-
-
-
-
Ghent, Belgien, 9000
- Ikke rekrutterer endnu
- Universitair Ziekenhuis Gent
-
Ledende efterforsker:
- Nicolas Deconinck
-
Kontakt:
- Nicolas Deconinck
- Telefonnummer: +3293321954
- E-mail: nicolas.deconinck@huderf.be
-
Leuven, Belgien, 3000
- Ikke rekrutterer endnu
- UZ Leuven
-
Ledende efterforsker:
- Liesbeth De Waele
-
Kontakt:
- Liesbeth De Waele
- Telefonnummer: +3216340610
- E-mail: liesbeth.dewaele@uzleuven.be
-
Liège, Belgien, 4000
- Ikke rekrutterer endnu
- C. H. R. de la Citadelle
-
Ledende efterforsker:
- Aurore Daron
-
Kontakt:
- Aurore Daron
- Telefonnummer: +3242238515
- E-mail: aurore.daron@chrcitadelle.be
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A*
- Ikke rekrutterer endnu
- University of Calgary - Alberta Children's Hospital
-
Ledende efterforsker:
- Jean Mah
-
Kontakt:
- Jean Mah
- Telefonnummer: 4039557816
- E-mail: jean.mah@albertahealthservices.ca
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3V4
- Ikke rekrutterer endnu
- BC Children's Hospital
-
Ledende efterforsker:
- Kathryn Selby
-
Kontakt:
- Kathryn Selby
- Telefonnummer: 60487523452121
- E-mail: kselby@cw.bc.ca
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Trukket tilbage
- The Hospital for Sick Children
-
-
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Det Forenede Kongerige, CB2 0QQ
- Rekruttering
- Addenbrooke's Hospital
-
Kontakt:
- Deepa Krishnakumar
- Telefonnummer: +4412232451514
- E-mail: deepa.krishnakumar@nhs.net
-
Ledende efterforsker:
- Deepa Krishnakumar
-
-
Greater London
-
London, Greater London, Det Forenede Kongerige, WC1N 3JH
- Rekruttering
- Great Ormond Street Hospital for Children
-
Ledende efterforsker:
- Mariacristina Scoto
-
Kontakt:
- Mariacristina Scoto
- Telefonnummer: +442079052639
- E-mail: mariacristina.scoto@gosh.nhs.uk
-
-
Oxfordshire
-
Oxford, Oxfordshire, Det Forenede Kongerige, OX3 9DU
- Rekruttering
- MDUK Oxford Neuromuscular Centre
-
Ledende efterforsker:
- Laurent Servais
-
Kontakt:
- Laurent Servais
- Telefonnummer: +441865741166
- E-mail: laurent.servais@paediatrics.ox.ac.uk
-
-
South Yorkshire
-
Sheffield, South Yorkshire, Det Forenede Kongerige, S10 2TH
- Rekruttering
- Sheffield Children's Hospital
-
Ledende efterforsker:
- Min Ong
-
Kontakt:
- Min Ong
- Telefonnummer: +441142717000
- E-mail: min.ong@nhs.net
-
-
Strathclyde
-
Glasgow, Strathclyde, Det Forenede Kongerige, G51 4TF
- Rekruttering
- Royal Hospital for Children
-
Kontakt:
- Shuko Joseph
- Telefonnummer: +441414516527
- E-mail: shuko.joseph2@nhs.scot
-
Ledende efterforsker:
- Shuko Joseph
-
-
West Midlands
-
Birmingham, West Midlands, Det Forenede Kongerige, B9 5SS
- Rekruttering
- Birmingham Heartlands Hospital
-
Kontakt:
- Deepak Parasuraman
- Telefonnummer: +441384456111
- E-mail: deepak.parasuraman@uhb.nhs.uk
-
Ledende efterforsker:
- Deepak Parasuraman
-
-
West Yorkshire
-
Leeds, West Yorkshire, Det Forenede Kongerige, LS1 3EX
- Rekruttering
- Leeds General Infirmary
-
Ledende efterforsker:
- Anne-Marie Childs
-
Kontakt:
- Anne-Marie Childs
- Telefonnummer: +441133923113
- E-mail: anne-marie.childs@nhs.net
-
-
-
-
Arkansas
-
Little Rock, Arkansas, Forenede Stater, 72202
- Rekruttering
- Arkansas Children's Hospital
-
Kontakt:
- Steven Giompoletti
- Telefonnummer: (501) 364-1430
- E-mail: giompolettis@archildrens.org
-
Ledende efterforsker:
- Kapil Arya, Dr.
-
-
California
-
San Diego, California, Forenede Stater, 92123
- Trukket tilbage
- Rady Childrens Hospital
-
Stanford, California, Forenede Stater, 94305
- Rekruttering
- Stanford University Medical Center
-
Kontakt:
- Lidia Choniawko
- Telefonnummer: (650) 304-8094
- E-mail: lidiacho@stanford.edu
-
Ledende efterforsker:
- Carolina Tesi Rocha, Dr.
-
-
Connecticut
-
Hartford, Connecticut, Forenede Stater, 06106
- Rekruttering
- Connecticut Children's Medical Center
-
Kontakt:
- Gyula Acsadi
- Telefonnummer: (860) 545-9460
- E-mail: gacsadi@connecticutchildrens.org
-
Ledende efterforsker:
- Gyula Acsadi, Dr.
-
-
Florida
-
Kissimmee, Florida, Forenede Stater, 34746
- Rekruttering
- Rare Disease Research FL LLC
-
Kontakt:
- Maria Cordero
- Telefonnummer: (407) 545-7610
- E-mail: maria.cordero@rarediseaseresearch.com
-
Ledende efterforsker:
- Renata Shih, Dr.
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611
- Rekruttering
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Kontakt:
- Alka Maheshwari
- Telefonnummer: (815) 444-6362
- E-mail: amaheshwari@luriechildrens.org
-
Ledende efterforsker:
- Nancy Kuntz, Dr.
-
-
Iowa
-
Iowa City, Iowa, Forenede Stater, 52242
- Rekruttering
- University of Iowa Stead Family Children's Hospital
-
Kontakt:
- Katherine Mathews
- Telefonnummer: (319) 356-1851
- E-mail: katherine-mathews@uiowa.edu
-
Ledende efterforsker:
- Katherine Mathews, Dr.
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21205
- Rekruttering
- The Johns Hopkins Hospital
-
Kontakt:
- Jessica Nance
- Telefonnummer: (410) 955-4259
- E-mail: jnance6@jhmi.edu
-
Ledende efterforsker:
- Jessica Nance, Dr.
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Rekruttering
- Boston Children's Hospital
-
Kontakt:
- Samantha Remis
- Telefonnummer: (617) 355-2752
- E-mail: samantha.remis@childrens.harvard.edu
-
Ledende efterforsker:
- Basil Darras, Dr.
-
-
Missouri
-
Columbia, Missouri, Forenede Stater, 65212
- Rekruttering
- The Curators of the University of Missouri on behalf of University of Missouri Health Care
-
Kontakt:
- Heather McHatton
- Telefonnummer: (573) 882-7619
- E-mail: heathermchatton@health.missouri.edu
-
Ledende efterforsker:
- Jane Emerson, Dr.
-
-
New York
-
New York, New York, Forenede Stater, 10032
- Rekruttering
- Columbia University Herbert Irving Comprehensive Cancer Center
-
Kontakt:
- Claudia Chiriboga
- Telefonnummer: (646) 426-3876
- E-mail: cac3@cumc.columbia.edu
-
Ledende efterforsker:
- Claudia Chiriboga, Dr.
-
-
North Carolina
-
Hillsborough, North Carolina, Forenede Stater, 27278
- Rekruttering
- Rare Disease Research NC, LLC
-
Kontakt:
- Norma Davis
- Telefonnummer: (470) 665-3051
- E-mail: norma.davis@rarediseaseresearch.com
-
Ledende efterforsker:
- Edward Smith, Dr.
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104
- Ikke rekrutterer endnu
- Children's Hospital Philadelphia - Neurology
-
Kontakt:
- Karen Monono
- Telefonnummer: (267) 425-0158
- E-mail: mononok@chop.edu
-
Ledende efterforsker:
- John Brandsema, Dr.
-
-
Texas
-
Flower Mound, Texas, Forenede Stater, 75028
- Rekruttering
- Neurology Rare Disease Center
-
Ledende efterforsker:
- Diana Castro, Dr.
-
Kontakt:
- Natalie Gomez
- Telefonnummer: (972) 999-1011
- E-mail: Natalie.Gomez@Neuromdcenter.com
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Texas Children's Hospital
-
Kontakt:
- Timothy Lotze
- Telefonnummer: (832) 822-1779
- E-mail: tlotze@bcm.edu
-
Ledende efterforsker:
- Timothy Lotze, Dr.
-
-
Virginia
-
Norfolk, Virginia, Forenede Stater, 23507
- Ikke rekrutterer endnu
- Childrens Hospital of The Kings Daughters
-
Kontakt:
- Crystal Proud
- Telefonnummer: (757) 668-9920
- E-mail: crystal.proud@chkd.org
-
Ledende efterforsker:
- Crystal Proud, Dr.
-
-
-
-
-
Utrecht, Holland, 3584-CX
- Ikke rekrutterer endnu
- UMC Utrecht
-
Ledende efterforsker:
- Ludo Van der Pol
-
Kontakt:
- Ludo Van der Pol
- Telefonnummer: +318875551166
- E-mail: w.l.vanderpol@umcutrecht.nl
-
-
-
-
-
Genova, Italien, 16147
- Ikke rekrutterer endnu
- Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS
-
Ledende efterforsker:
- Claudio Bruno
-
Kontakt:
- Claudio Bruno
- Telefonnummer: +391056362620
- E-mail: claudiobruno@gaslini.org
-
Messina, Italien, 98124
- Ikke rekrutterer endnu
- Azienda Ospedaliera Universitaria Policlinico G. Martino
-
Kontakt:
- Sonia Messina
- Telefonnummer: +39902217191
- E-mail: smessina@unime.it
-
Ledende efterforsker:
- Sonia Messina
-
Milan, Italien, 20133
- Ikke rekrutterer endnu
- Fondazione IRCCS Istituto Neurologico Carlo Besta
-
Ledende efterforsker:
- Riccardo Masson
-
Kontakt:
- Riccardo Masson
- Telefonnummer: +39223942371
- E-mail: riccardo.masson@istituto-besta.it
-
Roma, Italien, 00168
- Ikke rekrutterer endnu
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
-
Kontakt:
- Eugenio Mercuri
- Telefonnummer: +39630155586
- E-mail: mercuri.trial@policlinicogemelli.it
-
Ledende efterforsker:
- Eugenio Mercuri
-
-
Milano
-
Milan, Milano, Italien, 20162
- Ikke rekrutterer endnu
- Fondazione Serena Onlus - Centro Clinico Nemo
-
Ledende efterforsker:
- Emilio Albamonte
-
Kontakt:
- Emilio Albamonte
- Telefonnummer: +3929143371
- E-mail: emilio.albamonte@centrocliniconemo.it
-
-
-
-
-
Lodz, Polen, 93-338
- Ikke rekrutterer endnu
- Instytut Centrum Zdrowia Matki Polki
-
Ledende efterforsker:
- Lukasz Przyslo
-
Kontakt:
- Lukasz Przyslo
- Telefonnummer: +48422711371
- E-mail: lukasz.przyslo@iczmp.edu.pl
-
Poznan, Polen, 60-355
- Ikke rekrutterer endnu
- Uniwersytecki Szpital Kliniczny w Poznaniu
-
Ledende efterforsker:
- Barbara Steinborn
-
Kontakt:
- Barbara Steinborn
- Telefonnummer: +48618691255
- E-mail: bstein@ump.edu.pl
-
Warsaw, Polen, 02-091
- Ikke rekrutterer endnu
- Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego
-
Ledende efterforsker:
- Anna Kostera Pruszczyk
-
Kontakt:
- Anna Kostera Pruszczyk
- Telefonnummer: +48225992985
- E-mail: anna.kostera-pruszczyk@wum.edu.pl
-
-
-
-
-
Barcelona, Spanien, 08035
- Ikke rekrutterer endnu
- Hospital Universitari Vall d'Hebron - VHIR
-
Kontakt:
- Laura Costa Comellas
- Telefonnummer: +34934893156
- E-mail: lauracc89@gmail.com
-
Ledende efterforsker:
- Laura Costa Comellas
-
Valencia, Spanien, 46026
- Ikke rekrutterer endnu
- Hospital Universitari i Politecnic La Fe
-
Ledende efterforsker:
- Inmaculada Pitarch Castellano
-
Kontakt:
- Inmaculada Pitarch Castellano
- Telefonnummer: +34687450013
- E-mail: inmapitarch@hotmail.com
-
-
-
-
-
Essen, Tyskland, 45147
- Ikke rekrutterer endnu
- Universitaetsklinikum Essen
-
Ledende efterforsker:
- Heike Koelbel
-
Kontakt:
- Heike Koelbel
- Telefonnummer: +492017232508
- E-mail: heike.koelbel@uk-essen.de
-
-
Baden-Wurttemberg
-
Freiburg im Breisgau, Baden-Wurttemberg, Tyskland, 79106
- Ikke rekrutterer endnu
- Universitaetsklinikum Freiburg
-
Ledende efterforsker:
- Astrid Pechmann
-
Kontakt:
- Astrid Pechmann
- Telefonnummer: +4976127043951
- E-mail: astrid.pechmann@uniklinik-freiburg.de
-
Ulm, Baden-Wurttemberg, Tyskland, 89075
- Ikke rekrutterer endnu
- Universitaetsklinikum Ulm
-
Kontakt:
- Sebahattin Cirak
- Telefonnummer: +4973150057010
- E-mail: sebahattin.cirak@uniklinik-ulm.de
-
Ledende efterforsker:
- Sebahattin Cirak
-
-
Bavaria
-
München, Bavaria, Tyskland, 80337
- Ikke rekrutterer endnu
- Klinikum der Universitaet Muenchen
-
Kontakt:
- Astrid Blaschek
- Telefonnummer: +4989440055110
- E-mail: astrid.blaschek@med.uni-muenchen.de
-
Ledende efterforsker:
- Astrid Blaschek
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Is aged ≥5 to <18 years when completing the informed consent process, defined as providing informed assent according to local regulations and having a parent or guardian sign the ICF, and can comply with protocol
- requirements.
- Has documented historical genetic diagnosis of 5q-SMA.
- Currently receiving a stable SMA treatment regimen (nusinersen or risdiplam) and/or have a history of onasemnogene abeparvovec treatment
- Must be able to walk at least 50 meters without walking aids in the 6MWT at screening
Exclusion Criteria:
- Known medical condition that would interfere with an accurate assessment of SMA, confound the results of the study, or put the participant at undue risk, as assessed by the investigator
- Recent major surgery, except spinal fusion, within 3 months of screening or intends to have major surgery during the study
- Current or previous administration of antimyostatin therapies in the past 6 months
- Severe scoliosis (defined as curvature >40°) and/or contractures at screening. o History of spinal fusion within 6 months before screening or planned during the study
- Respiratory insufficiency, defined by the medical necessity for invasive or noninvasive ventilation for daytime treatment while awake. Ventilation used overnight or during daytime naps is acceptable.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: DBTP - ARGX-119 IV
Participants receive ARGX-119 IV during the DBTP |
Intravenous infusion of ARGX-119 |
|
Placebo komparator: DBTP - Placebo IV
Participants receive placebo IV during the DBTP |
Intravenous infusion of placebo |
|
Placebo komparator: ATEP - ARGX-119 IV
Participants receive ARGX-119 IV during the ATEP. Participants from ARGX-119 IV arm in the DBTP will receive placebo once to maintain the DBTP blinding |
Intravenous infusion of placebo Intravenous infusion of ARGX-119 |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of AEs
Tidsramme: Up to 124 weeks
|
Adverse Events |
Up to 124 weeks
|
|
Incidence of SAEs
Tidsramme: Up to 124 weeks
|
Serious Adverse Events |
Up to 124 weeks
|
|
Change in RHS total score from baseline to week 24 of the double blinded treatment period (DBTP)
Tidsramme: Up to 24 weeks
|
The RHS (Revised Hammersmith Scale) is a validated 36-item scale developed to evaluate the spectrum of gross motor function. Maximum total score; 69 (optimal motor function) |
Up to 24 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline over time for the 6MWT - distance and fatigue index
Tidsramme: Up to 124 weeks
|
In the 6MWT (6-minute walk test) participants will be instructed to walk as fast as possible without jogging or running along a 25- meter linearly marked course for 6 minutes without using walking devices or assistance. Distance walked over the entire 6-minute period, and other parameters, will be determined |
Up to 124 weeks
|
|
ARGX-119 serum concentrations over time
Tidsramme: Up to 124 weeks
|
ARGX-119 serum concentrations over time |
Up to 124 weeks
|
|
Incidence of antidrug antibodies (ADA) against ARGX-119
Tidsramme: Up to 124 weeks
|
Incidence of antidrug antibodies (ADA) against ARGX-119 |
Up to 124 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ARGX-119-24-SMA-2001
- 2025-523496-32-00 (Ctis)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .